about
Allozyne, Inc. is a privately held next generation protein optimization company committed to the development of improved biological therapeutics to treat multiple areas of unmet medical need. Allozyne’s two proprietary technology platforms enable the incorporation of amino acids analogues, at any specified position, into existing biologics leading to improved efficacy, tolerability and pharmacology.